-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-disposition-comments.pdf
August 20, 2024 - of Comments: Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer … Effectiveness Review Disposition of Comments Report
Title: Treatment of Stages I-III Squamous Cell Anal Cancer … Treatment of Stages I–III
Squamous Cell Anal Cancer: A Systematic Review. … For rare diseases such as nonmetastatic squamous cell
anal cancer, regulatory agencies have published … Source: https://effectivehealthcare.ahrq.gov/products/anal-cancer-treatment/research
Published Online
-
effectivehealthcare-admin.ahrq.gov/products/aces-2010/white-paper
July 01, 2019 - At the University of Arizona, he conducted health communication research at the Arizona Cancer Center … Buller moved to Denver where he was a Senior Scientist at AMC Cancer Research Center (1997–2002) and … He has been a consultant on health communication to the National Cancer Institute, U.S. … Division of Cancer Control and Population Sciences at the National Cancer Institute. … She is also a founding member of the Division of Cancer Control and Population Science's Social Media
-
effectivehealthcare-admin.ahrq.gov/health-topics/x-rays?page=0
July 29, 2016 - Mammograms use x-rays to look for breast cancer. … Testing for Coronary Artery Disease
Decision Aid Archived March 9, 2016
Is Lung Cancer … Systematic Review Archived September 10, 2014
Imaging Tests for the Staging of Colorectal Cancer … Archived December 17, 2013
Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer … Research Protocol Archived May 21, 2013
Imaging Tests for the Staging of Colorectal Cancer
-
effectivehealthcare-admin.ahrq.gov/health-topics/x-rays
July 29, 2016 - Mammograms use x-rays to look for breast cancer. … Testing for Coronary Artery Disease
Decision Aid Archived March 9, 2016
Is Lung Cancer … Systematic Review Archived September 10, 2014
Imaging Tests for the Staging of Colorectal Cancer … Archived December 17, 2013
Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer … Research Protocol Archived May 21, 2013
Imaging Tests for the Staging of Colorectal Cancer
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-evidence-summary-updated-1.pdf
October 01, 2021 - Continued on page 2
2
Background and Purpose
Breast cancer is the most common new cancer diagnosis … among women in the United
States and the second most common cause of cancer death. … (or breast cancer prophylaxis). … New neoplasms . . nd nd nd . … Complications delaying other cancer
treatments
nd nd nd nd nd nd
Thromboembolic events ◆◆ DVT or
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
February 01, 2011 - cancer but no KD codes); (2) cancer
and intermittent KD (beneficiaries with cancer and occasional KD … diag-
noses); (3) cancer and predialysis (beneficiaries with cancer and non-
dialysis KD); and (4) cancer … The
cancer and intermittent KD group grew from
5 percent to 9 percent, and the cancer only
group … only
Cancer & intermittent KD
Cancer & predialysis
Cancer & dialysis
Figure 3: Size of the ESA user … only
Cancer & intermittent KD
Cancer & predialysis
Cancer & dialysis
Implementation
of Cancer NCD
-
effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-topics/methods
December 01, 2019 - Similarly, the request for a review of tests for prostate cancer may neglect to consider the role of … Initial ambiguous claim
FFDM may be a useful alternative to SFM in screening for breast cancer. … contrasted were benefits of avoiding biopsy versus harms of delaying initiation of treatment for undetected tumors … avoid the adverse events of biopsy with potentially negligible risk of delayed treatment for undetected tumor … HER2 Testing to Manage Patients With Breast Cancer or Other Solid Tumors.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
May 01, 2019 - • Women who undergo IVF demonstrated
an increased risk of ovarian neoplasms and
colorectal malignancies … There is
no evidence of a difference in invasive ovarian
cancers (low SOE). … IVF was associated with a
statistically significant increased risk of
all ovarian neoplasms and borderline … ovarian tumors, and colorectal cancer
No difference: IVF however was not
associated with an increased … Effects
of fertility drugs on cancers other than breast and
gynecologic malignancies.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
February 01, 2017 - to optimize outcomes when considering
the patient’s overall health, life expectancy, comorbidities, tumor … biology, anatomy, previous treatment
including prior radiation at or near current site of treatment, tumor … tissue response history to
local and systemic therapies, and other factors related to the patient, tumor … Introduction
Bone metastases are a common manifestation of
malignancy that can cause severe and debilitating … tissue response history to local and systemic
therapies, and other factors related to the patient, tumor
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0488_12-27-2011.pdf
January 01, 2011 - Results of Topic Selection Process & Next Steps
Primary diagnosis and staging of pancreatic cancer … Staff-Generated PICO
Population(s): People (primarily adults) at high risk for pancreatic cancer ( … Which imaging test or test that can “see” some functions of a cancer (e.g., blood flow,
consumption … )
Definitive cure of pancreatic cancer is more likely with early diagnosis. … There currently exists no standard procedure for the diagnosis and staging
of pancreatic cancer.
-
effectivehealthcare-admin.ahrq.gov/products/uterine-fibroids/research-protocol
May 01, 2019 - background
Most women will develop one or more uterine fibroids (i.e., leiomyomata), benign smooth muscle tumors … among those with symptoms in part due to earlier age at onset of fibroids with larger and more numerous tumors … address the potential harms associated with morcellation, as well as an exploration of patient and tumor … Key Question 3
What is the risk of cancer dissemination from morcellation of uterine fibroids at the … Non-FDA labeled indications : Breast cancer; In vitro fertilization; Ovarian cancer; Premenstrual
-
effectivehealthcare-admin.ahrq.gov/products/genitourinary-syndrome/research
March 01, 2025 - cancers, a high risk of cancer, or conditions such as primary ovarian insufficiency, women experiencing … Over half of studies excluded women with a history of cancer or at high risk for cancer, while only 6 … for cancer. … Few studies enrolled women with a history of breast or gynecologic cancers. … Few studies enrolled women with a history of breast or gynecologic cancers.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
August 01, 2024 - Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer … Review
Comparative Effectiveness Review
Number 273
Treatment of Stages I–III Squamous
Cell Anal Cancer … • Evidence remains uncertain for other comparisons including local excision versus
CRT for stage I cancer … insufficient for remaining comparisons (not shown in Table A) including local excision
for early-stage cancer … Treatment of Stages I–III
Squamous Cell Anal Cancer: A Systematic Review.
-
effectivehealthcare-admin.ahrq.gov/products/aces-2010/white-paper-2010
July 01, 2019 - At the University of Arizona, he conducted health communication research at the Arizona Cancer Center … Buller moved to Denver where he was a Senior Scientist at AMC Cancer Research Center (1997–2002) and … Linda Fleisher, M.P.H., Ph.D(c)., is the Assistant Vice President of Fox Chase Cancer Center's Office … Bradford (Brad) Hesse, Ph.D. , is Chief of the National Cancer Institute's Health Communication and … Since coming to the National Cancer Institute (NCI), Dr.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_consumer.pdf
May 01, 2016 - A biopsy tells if the lump is breast cancer. … It also does not cover
treatments for breast cancer.
1
Finding Breast Cancer
Breast cancer can … It looks for changes in breast tissue that may be cancer. … In a few cases, a biopsy can miss breast cancer. … � If cancer is found, the report will tell you the kind of cancer you
have.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-199-skin-cancer.pdf
December 01, 2017 - , including basal cell
carcinoma (BCC) and squamous cell
carcinoma (SCC), are the most common
malignancies … Conversely, use of topical drugs is
generally limited to primary, superficial tumors. … expectancy, are frail, or who are immunocompromised
(e.g., have chronic lymphocytic leukemia and other
malignancies … interventions: any
surgical treatment, regardless of margin control, removes
all clinically visible tumor … Centers for Disease Control and Prevention Skin Cancer
Statistics. 2015. http://www.cdc.gov/cancer/skin
-
effectivehealthcare-admin.ahrq.gov/health-topics/lymphoma
June 23, 2022 - Y
Z
Health Topics
Lymphoma
Description
Lymphoma is a cancer … Targeted therapy uses substances that attack cancer cells without harming normal cells. … Biologic therapy boosts your body's own ability to fight cancer. … NIH: National Cancer Institute
Source
https://medlineplus.gov/lymphoma.html
Products
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-measures-framework_research.pdf
April 01, 2010 - the National Cancer Institute and other Federal agencies initiated the Cancer Care
Quality Measurement … The framework focuses on the “end-of-life” stage in the National Cancer Institute’s
cancer continuum … For certain cancer populations, “seriously ill” or other terms such as
“living with advanced cancer” … Quality of cancer care
measures’ project symptom management/end-of-
life cancer technical panel. 2006 … Quality
measures for supportive cancer care: The cancer
quality-ASSIST (Assessing Symptoms Side
Effects
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-framework_research.pdf
April 01, 2010 - the National Cancer Institute and other Federal agencies initiated the Cancer Care
Quality Measurement … The framework focuses on the “end-of-life” stage in the National Cancer Institute’s
cancer continuum … For certain cancer populations, “seriously ill” or other terms such as
“living with advanced cancer” … Quality of cancer care
measures’ project symptom management/end-of-
life cancer technical panel. 2006 … Quality
measures for supportive cancer care: The cancer
quality-ASSIST (Assessing Symptoms Side
Effects
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_disposition-comments.pdf
July 03, 2012 - Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment
Source: http … Research Review Disposition of Comments Report
Research Review Title: Multigene Panels in Prostate Cancer … Multigene Panels in Prostate Cancer Risk Assessment. … A summary of the genetics of prostate
cancer as well as of its heritability would have been welcome, … part of the introduction has been re-
organized, to make information on genetics of
prostate cancer